Sarah HeininBench to BiotechIs a universal flu vaccine finally on the way?Last week, a group out of Mount Sinai published early results from a clinical trial for a potential universal flu vaccine. This concept…Dec 18, 2020Dec 18, 2020
Sarah HeininBench to BiotechInvestment gaps in cancer biotech (and why you should bet on Texas)This year, I will be helping to launch the Accelerator for Cancer Therapeutics here in Houston, Texas. Let’s be clear — Houston is NOT…Dec 14, 2020Dec 14, 2020
Sarah HeininBench to BiotechWeekly Roundup: December 11th, 2020Covid vaccines one approval away from being sold out everywhereDec 11, 2020Dec 11, 2020
Sarah HeininBench to BiotechBispecific therapeutics are about to make a big comebackIn June, Abbvie announced that they are willing to pay $750M upfront to Genmab to partner on their bispecific therapeutic pipeline, with…Dec 10, 2020Dec 10, 2020
Sarah HeininBench to BiotechWhy I think quitting academia is the smart thing to doI’m here to break some cows and kill some eggs. If you are a PhD but not yet on a professorship track, you should quit academia. Full stop…Dec 10, 2020Dec 10, 2020